Geneos Wealth Management’s Defiance Quantum ETF QTUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Sell
13,083
-5,163
-28% -$742K 0.04% 362
2026
Q1
$1.96M Sell
18,246
-2,925
-14% -$335K 0.05% 359
2025
Q4
$2.32M Sell
21,171
-287
-1% -$31.6K 0.06% 326
2025
Q3
$2.25M Buy
21,458
+1,193
+6% +$114K 0.06% 327
2025
Q2
$1.86M Buy
20,265
+595
+3% +$48.1K 0.05% 382
2025
Q1
$1.47M Hold
19,670
0.05% 367
2024
Q4
$1.6M Buy
19,670
+470
+2% +$32.4K 0.06% 332
2024
Q3
$1.2M Hold
19,200
0.05% 366
2024
Q2
$1.21M Hold
19,200
0.05% 329
2024
Q1
$1.18M Hold
19,200
0.05% 326
2023
Q4
$1.04M Buy
+19,200
New +$948K 0.05% 317
2021
Q4
Sell
-162
Closed -$8K 2856
2021
Q3
$8K Hold
162
﹤0.01% 2314
2021
Q2
$8K Hold
162
﹤0.01% 2302
2021
Q1
$7K Hold
162
﹤0.01% 2547
2020
Q4
$7K Hold
162
﹤0.01% 2381
2020
Q3
$5K Buy
+162
New +$5.32K ﹤0.01% 2194

Other funds holding QTUM

Geneos Wealth Management's QTUM Position: Q2 2026 in Review

Geneos Wealth Management reduced its Defiance Quantum ETF (QTUM) stake by 28% in Q2 2026, selling an estimated $742K and leaving 13,083 shares worth $2.16M. The position accounts for 0.04% of the portfolio, ranked #362.

Geneos Wealth Management first reported a position in QTUM in Q3 2020 and has held it in 16 quarters since. The position peaked at $2.32M in Q4 2025. 562 funds tracked by Wall St. Rank hold QTUM as of Q2 2026.

  • Geneos Wealth Management held 13,083 shares of Defiance Quantum ETF worth $2.16M as of Q2 2026.
  • Geneos Wealth Management sold 5,163 Defiance Quantum ETF shares in Q2 2026, an estimated $742K.
  • Defiance Quantum ETF made up 0.04% of Geneos Wealth Management's portfolio in Q2 2026, its #362 holding.
  • Geneos Wealth Management first reported a position in Defiance Quantum ETF in Q3 2020 and has held it in 16 quarters since.
  • Geneos Wealth Management's Defiance Quantum ETF position peaked at $2.32M in Q4 2025.
  • 562 funds tracked by Wall St. Rank held Defiance Quantum ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.